Solvay   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Brussels Belgium (1863)
Status: Acquired by Abbott (2009)

Organization Overview

First Clinical Trial
2000
NCT00266721
First Marketed Drug
1962
dydrogesterone (gynorest)
First NDA Approval
1962
dydrogesterone (gynorest)
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Solace Pharmaceuticals | SOLVAY | Solvay Biologicals | Solvay Pharmaceuticals